Odyssey Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Odyssey Health yıllık ortalama 33.6% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 13.1% annual.

Anahtar bilgiler

33.6%

Kazanç büyüme oranı

36.0%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	8.9%
Gelir büyüme oranı	n/a
Özkaynak getirisi	140.7%
Net Marj	n/a
Son Kazanç Güncellemesi	30 Apr 2024

Yakın geçmiş performans güncellemeleri

Güncelleme yok

Recent updates

Gelir ve Gider Dağılımı

Odyssey Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

OTCPK:ODYY Gelir, gider ve kazançlar (USD Millions )
Tarih	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Apr 24	11	3	0
31 Jan 24	11	4	0
31 Oct 23	-4	4	0
31 Jul 23	-6	5	0
30 Apr 23	-7	5	1
31 Jan 23	-9	7	1
31 Oct 22	-9	7	1
31 Jul 22	-8	7	1
30 Apr 22	-9	7	2
31 Jan 22	-19	6	2
31 Oct 21	-18	5	2
31 Jul 21	-17	5	2
30 Apr 21	-15	4	1
31 Jan 21	-4	3	0
31 Oct 20	-4	3	0
31 Jul 20	-4	4	0
30 Apr 20	-26	26	0
31 Jan 20	-25	25	0
31 Oct 19	-25	25	0
31 Jul 19	-23	23	0
30 Apr 19	0	0	0
31 Jan 19	0	0	0
31 Oct 18	0	0	0
31 Jul 18	0	0	0
30 Apr 18	0	0	0
31 Jan 18	0	0	0
31 Oct 17	0	0	0
31 Jul 17	0	0	0
30 Apr 17	0	0	0
31 Jan 17	0	0	0
31 Oct 16	0	0	0
31 Jul 16	0	0	0
30 Apr 16	0	0	0
31 Jan 16	0	0	0
31 Oct 15	0	0	0
31 Jul 15	0	0	0

Kaliteli Kazançlar: ODYY büyük bir tek seferlik kazanç ile $14.7M, 30th April, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: ODYY geçmişte karlı hale geldi.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: ODYY son 5 yılda karlı hale geldi ve kazançlarını yıllık 33.6% oranında artırdı.

Büyüme Hızlandırma: ODYY son bir yılda karlı hale geldi, bu da kazanç büyüme oranının 5 yıllık ortalamayla karşılaştırılmasını zorlaştırıyor.

Kazançlar vs. Sektör: ODYY son bir yılda karlı hale geldi ve bu durum, geçmiş yıl kazanç büyümesinin Medical Equipment sektörüyle ( 12.2% ) karşılaştırılmasını zorlaştırıyor.

Özkaynak Getirisi

Yüksek ROE: ODYY 'nin Özsermaye Getirisi ( 140.7% ) ödenmemiş olarak değerlendirilmektedir.

Odyssey Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Recent updates

Odyssey Health, Inc. announced delayed annual 10-K filing

Odyssey Health, Inc. announced that it has received $0.3 million in funding

Odyssey Health, Inc. announced delayed 10-Q filing

Oragenics, Inc. (NYSEAM:OGEN) completed the acquisition of Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc.

Oragenics, Inc. (NYSEAM:OGEN) entered into an Asset Purchase Agreement to acquire Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc.

Odyssey Health, Inc. Presents Concussion Treatment Data At the Military Health System Research Symposium -MHSRS

Odyssey Health, Inc. (OTCPK:ODYY) executed a non- binding letter of intent to acquire Speranza Therapeutics, Inc.

Odyssey Health, Inc. Appoints Jeffrey Conroy as Director

Odyssey Health, Inc. to Develop Intranasal Field- Deliverable Nerve Agent Antidote

Odyssey Health, Inc. Announces Resignation of Jeffrey Conroy as Director

Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development

Odyssey Health, Inc., Annual General Meeting, Jan 12, 2023

Odyssey Health Inc. Announces Expansion of Executive Team

Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device

Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug

Odyssey Health, Inc. Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II

Odyssey Health, Inc. Announces the Successful Completion of Safety Measures for Their Phase I Multi-Day Ascending Dosing (Mad) Clinical Trial

Odyssey Health, Inc. Announces Positive Results from its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion

Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug

Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug

Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

Odyssey Health, Inc. Names Vice Admiral (r) Timothy Szymanski to the Military Advisory Board

Odyssey Group International Announces Formation of Military Advisory Board

Odyssey Group International, Inc. Continues Enrollment of its First in Kind Human Clinical Trial of its Proprietary Drug Compound Intended to Treat Concussion

Odyssey Group International, Inc. Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion

Odyssey Group International, Inc. Approves to Start Human Trial to Treat Concussion

Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial

Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Concussion

Odyssey Group International, Inc. announced delayed 10-Q filing

Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion

Odyssey Group International, Inc. Announces the Completion of the Food and Drug Administration (FDA) Required Toxicology Studies Designed to Support Clinical Trials with Prv-002

Odyssey Group International Announces Completion of Novel Device for Nasal Delivery of Concussion Drug Candidate

Odyssey Group International, Inc. announced a financing transaction

Odyssey Group International, Inc. announced delayed annual 10-K filing

Odyssey Group International, Inc. announced that it expects to receive $10.6 million in funding from The EquiLux Group, LP, Lincoln Park Capital, LLC

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin